Research ArticleClinical Investigation
FDG and L-[1-11C]-Tyrosine Imaging of Soft-Tissue Tumors Before and After Therapy
Annemieke C. Kole, Boudewijn E.C. Plaat, Harald J. Hoekstra, Willem Vaalburg and Willemina M. Molenaar
Journal of Nuclear Medicine March 1999, 40 (3) 381-386;
Annemieke C. Kole
Boudewijn E.C. Plaat
Harald J. Hoekstra
Willem Vaalburg


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
FDG and L-[1-11C]-Tyrosine Imaging of Soft-Tissue Tumors Before and After Therapy
Annemieke C. Kole, Boudewijn E.C. Plaat, Harald J. Hoekstra, Willem Vaalburg, Willemina M. Molenaar
Journal of Nuclear Medicine Mar 1999, 40 (3) 381-386;
Jump to section
Related Articles
- No related articles found.
Cited By...
- 11C-Methionine vs. 18F-FDG PET in Soft Tissue Sarcoma Patients Treated with Neoadjuvant Therapy: Preliminary Results
- Tumor Cell Metabolism Imaging
- Imaging Bone and Soft Tissue Tumors with the Proliferation Marker [18F]Fluorodeoxythymidine
- Detection and Grading of Soft Tissue Sarcomas of the Extremities with 18F-3'-Fluoro-3'-Deoxy-L-Thymidine
- 18F-FDG PET for the Diagnosis and Grading of Soft-Tissue Sarcoma: A Meta-Analysis
- Whole-Body Tumor Imaging Using PET and 2-18F-Fluoro-L-Tyrosine: Preliminary Evaluation and Comparison with 18F-FDG
- L-1-11C-Tyrosine PET in Patients with Laryngeal Carcinomas: Comparison of Standardized Uptake Value and Protein Synthesis Rate
- Radiolabeled Amino Acids: Basic Aspects and Clinical Applications in Oncology
- Imaging of Soft-Tissue Tumors Using L-3-[Iodine-123]Iodo-{{alpha}}-methyl-tyrosine Single Photon Emission Computed Tomography: Comparison with Proliferative and Mitotic Activity, Cellularity, and Vascularity